National and Kapodistrian University of Athens
Αγγειογενετικοί παράγοντες (αγγειακός ενδοθηλιακός αυξητικός παράγοντας, πλακουντιακός αυξητικός παράγοντας) στο αμνιακό υγρό δεύτερου τριμήνου κύησης
Abstract
dc:descriptionAngiogenesisIn this first chapter, the role of angiogenesis in physiological and pathologicalcondititons is explained. The mechanism of angiogenesis and vasculogenesis as wellas their stages are also cited. This chapter describes the main angiogenic factors:VEGF, PIGF, FGF, IGF, TGF, PlGF.The two main types of angiogenesis are also described. These are the sproutingangiogenesis and the intussusceptive angiogenesis. The importance of angiogenesis inpathological conditions in cancer and in the ovarian hyperstimulation syndrome aswell as the role of therapeutic angiogenesis is also highlighted in this chapter.Finally, angiogenesis in pregnancy in all stages from conception until term as well asthe role of the main angiogenic factors are discussed.II. Pathological AngiogenesisThis chapter refers to angiogenesis which characterizes pathological pregnancies. In specific, the characteristics of angiogenesis in pregnancies complicated bypreeclampsia or IUGR and the differences compared with normal pregnancies andphysiological angiogenesis are highlighted. Amniotic FluidIn this chapter, the role of amniotic fluid and its abnormalities in normal andpathological pregnancies are discussed.IV. Angiogenesis and Amniotic FluidThis chapter analyzes the presence of the angiogenic factors and their receptors in theamniotic fluid. Several studies, which prove their presence in amniotic fluid andchanges in their concentrations during normal and pathological pregnancies are stated.The Specific part includes the following:I. Hypothesis and AimThis study was based on the hypothesis of a possible relation between angiogenicfactors (VEGF, PlGF) in the second trimester amniotic fluid and maternal, gestationaland neonatal characteristics. This relation has been proved studying these factors inmaternal plasma compared with the above parameters by Mijal et al. The aim of thestudy was also the detrmination of reference values of VEGF and PlGF inmidtrimetser amniotic fluid, which has not been investigated until today according tothe literature, to the best of our knowledge.II. Subjects and methodsThe Ethics Committee of our teaching hospital approved the study protocol. Writteninformed consent was obtained by all participants. Two hundred and twenty-sevenGreek women with singleton pregnancies, who underwent amniocentesis at a median(range) gestational age of 17.56 (14.72-25) for standard genetic indications during aperiod of 16 months, were prospectively recruited. The amniotic fluid was separatedin 3 parts. The biggest part was used for the determination of the karyotype. Thesecond part was tested with PCR for Mycoplasma Hominis and ChlamydiaTrachomatis as well as the culture of aerobic and anaerobic bacteria. The third partwas collected and centrifuged and the supernatant and fluid was stored at -80 Celsius.ELISA was used for the determination of the concentrations of VEGF and PlGF. ResultsRefernce values (median {range}) were 126.56 (45.30-518.92) pg/ml and 18.81(5.61-168.61) pg/ml for amniotic fluid VEGF and PlGF respectively. Amniotic fluidconcentrations of both VEGF and PlGF increased with increasing gestational age atthe time of amniocentesis. Furthermore, amniotic fluid concentrations of PlGFpositively correlated with birth-weight. The effect of maternal age and weight, BMI,race, parity, smoking , delivery mode and fetal gender on amniotic fluidconcentrations of VEGF and PlGF was not significant.IV. ConclusionsThe data of this study provide a useful set of VEGF and PlGF reference values inmidpregnancy amniotic fluid. The study also investigates possible associations amongestablished risk factors for adverse pregnancy outcomes and concentrations of secondtrimester amniotic fluid angiogenic factors in normal pregnancies.The concentrations of both factors increase with increasing gestational age. Overall and according to other studies, both angiogenic factors increase between the first andsecond trimester, consistent with an increased level of angiogenesis as the placentadevelops.Furthermore, our data suggest a positive correlation between amniotic fluid PlGFconcentrations and neonatal birthweight. In some studies, lower levels of PlGF havebeen reported in women who delivered small-for-gestational-age infants, suggestingan antiangiogenic state.Advantages of this study include the prospective collection of amniotic fluid samplesin a clearly defined population, the use of an uncomplicated pregnancy group and theexploration of little-studied characteristics.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Papapostolou, Thalis-Konstantinos
- Παπαποστόλου, Θαλής-Κωνσταντίνος
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/40731